November 18, 2026
Health news, explained with evidence
LIVE

Molecular Signatures and Epstein-Barr Virus Markers in Oral Lichen Planus Explored in New Study

🧠 AI Analysis 2 min read 👁 2

Researchers at Tabriz University of Medical Sciences investigated immune pathways and viral markers in oral tissues from patients with oral lichen planus, finding broad inflammatory changes but no definitive EBV-driven disease program.

🧠AI Analysis

Key points

  • Tabriz University researchers examined 35 OLP patients and 35 controls for EBV markers and immune pathways.
  • OLP tissues showed marked upregulation of inflammatory, interferon, and pyroptosis-related genes.
  • No host marker retained a significant EBV association after adjusting for disease status.

A team of researchers from Tabriz University of Medical Sciences has published a new investigation examining the molecular and viral factors associated with oral lichen planus (OLP), a chronic inflammatory condition affecting the oral mucosa. The study analyzed oral tissue samples from 35 patients diagnosed with OLP and 35 control subjects to evaluate the presence of Epstein-Barr virus (EBV) DNA alongside specific viral transcripts, inflammatory genes, interferon responses, and microRNA expressions.

The findings showed that OLP tissues were characterized by a prominent upregulation of pathways related to inflammation, interferon-gamma, interferon-alpha, and TNF-NF-kappaB signaling, as well as transcriptional priming of pyroptosis-related pathways. While EBV DNA was identified in 8 of the 35 OLP samples and 4 of the 35 controls, the variance was not statistically significant. Among the viral transcripts evaluated, LMP1 was detected most frequently. Furthermore, specific microRNAs such as miR-155-5p, miR-146a-5p, miR-21-5p, and miR-142-3p showed elevated levels in OLP tissues, whereas miR-27b-3p was decreased.

The authors note important limitations, emphasizing that the EBV-positive subgroups and transcript-detectable subsets were small, and that pooled comparisons could be subject to disease status confounding. Consequently, the data suggest that the primary molecular signature is OLP-associated rather than directly driven by a distinct EBV inflammatory program. What to know: While the research highlights distinct inflammatory and microRNA alterations in OLP, the relationship with Epstein-Barr virus remains exploratory; patients should consult a healthcare professional regarding any chronic oral symptoms.

The primary molecular signature was OLP-associated; after adjustment for disease status, no host marker retained a significant EBV association following correction for multiple testing.

Source Nature Health Sciences — nature.com/articles/s41598-026-81133-5 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.